Leukemia Current Events | Leukemia News | 8
|
| Page
8 of
10 |
196 Results |
|
|
|
Sort By:
Page Views | Date |
Stem cells: Deathly awakening by interferon
After injuries with blood loss, the body quickly needs to restore the vital blood volume. This is accomplished by a special group of stem cells in the bone marrow. view more (2009-02-12)
New genes involved in Acute Lymphoblastic Leukemia play fundamental role in prognosis of the disease
The inactivity or "silence" of certain genes plays a fundamental role in the prognosis of acute lymphoblastic leukemia (ALL) as well as in response to treatment, according to the results of research involving a team made up of specialists from the University Hospital of Navarra and the Centre for Applied Medical Research (CIMA) at the... view more... (2009-02-09)
Mutation in blood stem cells provides clues to cancer development
The discovery suggests that development of a very specific inhibitor at the stem-cell level, to interfere with the pathway leading to the disease, could improve treatment for the cancer-causing disorder. view more (2006-04-07)
Silenced genes as a warning sign of blood cancer
In many types of cancer, parts of the genetic material of tumor cells are switched off by chemical labels called methyl groups. This kind of methyl labeling ranges among the epigenetic changes that do not change the sequence of DNA building blocks. view more (2009-08-05)
Drug that battles resistance to leukemia pill Gleevec 'extremely effective' against cancer
An experimental therapy that battles drug resistance in Chronic Myeloid Leukemia (CML) has proved "extremely effective" in fighting cancer, giving patients for whom all conventional therapies have failed another option. view more (2006-06-15)
Novel epigenetic markers of melanoma may herald new treatments for patients
Melanoma is the most serious form of skin cancer, diagnosed in more than 50,000 new patients in the United States annually. While the rate of incidences continues to rise, survival rate has not improved and the race is on to find the genetic and cellular changes driving melanoma and to devise new means of detection and treatment. view more (2009-06-30)
Received Truth Turned On End In Cancer Research
It has long been the accepted view of cancer researchers that there is a difference between the mechanism behind the development of leukemias, on the one hand, and solid tumors like breast cancer, prostate cancer, gastrointestinal cancer, etc, on the other. A research team at the Section for Clinical Genetics at Lund University in Sweden is now... view more... (2004-04-06)
UC Davis researchers report new molecule that targets leukemia and lymphoma cells
UC Davis Cancer Center researchers have developed a novel peptide that binds to the surface of leukemia and lymphoma cells with extremely high affinity, specificity and stability, and demonstrates remarkable promise as a tool to help image tumors and deliver anti-cancer drugs. view more (2006-06-13)
Study finds overall health and quality of life intact 10 years after stem-cell transplantation
Survivors of stem-cell transplantation for blood cancers can expect to be just about as healthy 10 years later as adults who have never had a transplant, according to a new study by researchers at Fred Hutchinson Research Cancer Center. view more (2005-09-19)
New Class of RNA Molecules May Be Important in Human Cancer
Research here shows that an obscure form of RNA, part of the protein-making machinery in all cells, might play an important role in human cancer. view more (2007-09-12)
Early Phase II results show bosutinib safe, effective for CML
A new drug for chronic myelogenous leukemia works for patients who have developed resistance to frontline therapy and causes fewer side effects than other medications in its class, a research team led by scientists at The University of Texas M. D. Anderson Cancer Center reports at the 49th annual meeting of the American Society of Hematology. view more (2007-12-11)
Stowers scientists clarify role of tumor suppressor gene
Jiwang Zhang, Ph.D., formerly a Senior Research Associate at the Stowers Institute for Medical Research, and Linheng Li, Ph.D., Associate Investigator, are credited as the first and last authors, respectively, on a paper highlighting several previously unknown functions of phosphatase and tensin homolog (PTEN), an important tumor suppressor gene. view more (2006-04-24)
Waking up dormant HIV
HAART (highly active anti-retroviral therapy) has emerged as an extremely effective HIV treatment that keeps virus levels almost undetectable; however, HAART can never truly eradicate the virus as some HIV always remains dormant in cells. view more (2009-03-17)
Growth factors given with chemotherapy associated with increased risk of blood diseases
Women with breast cancer who receive compounds that stimulate white blood cell production to help their bodies better tolerate chemotherapy are at an increased risk of developing a type of leukemia or a condition called myelodysplastic syndrome. view more (2007-02-07)
Scientists to assess effects of multiple copies of genes on disease risk
Scientists at Washington University School of Medicine in St. Louis and the biotech firm Nimblegen Systems Inc. have successfully tested a technique for identifying newly recognized DNA variations that may influence disease risk. view more (2007-01-31)
Single microRNA fine-tunes innate immune response
A single microRNA, microRNA-223, in mice controls the production and activation of granulocytes, white blood cells essential for host defense against invading pathogens. view more (2008-02-20)
The 2001 Jeanne Loubaresse - Institut Curie European Prize : Pr Peter E. Nielsen awarded for his works on PNAs, chimera molecules analogues to DNA
The 2001 Jeanne Loubaresse - Institut Curie european prize was delivered the 25th of June 2002 by Pr Claude Héle'ne during a ceremony taking place at the Institut Curie. Worth 60 000 euros, it awards Peter E. Nielsen, professor at the Panum Institute (University of Copenhagen, Denmark), "inventor" of PNAs (Polyamide Nucleic Acids), chimera... view more... (2002-07-02)
Aging stem cells in mice may hold answers to diseases of the aged, Stanford study finds
As stem cells in the blood grow older, genetic mutations accumulate that could be at the root of blood diseases that strike people as they age, according to work done in mice by researchers at the Stanford University School of Medicine. view more (2007-06-07)
Research to provide information of long-term effects of childhood cancer treatment to parents
Researchers from the neuropsychology department and pediatric hematology/oncology department at Rhode Island Hospital and its Hasbro Children's Hospital have published the results of their findings on parents' needs for information about the neurocognitive late effects (NCLE) of treatment for childhood cancer. view more (2009-02-05)
New studies identify advances in treatment of chronic myeloid leukemia
Offering promise in the battle against cancer, the results from five studies highlighting new advances in the treatment of chronic myeloid leukemia (CML) - a slow-progressing, malignant bone marrow cancer - will be presented at the 47th Annual Meeting of the American Society of Hematology. view more (2005-12-12)
|
|
| Page
8 of
10 |
196 Results |
|
|
|
Sort By:
Page Views | Date |
|
